GlobeImmune's Series D Round

GlobeImmune raised a round of funding on May 05, 2009. Investors include Celgene.

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's Series D Round: